Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia.

ABSTRACT:

Purpose

To assess the feasibility of ferumoxytol-enhanced anesthesia-free cardiac MRI in neonates and young infants for complex congenital heart disease (CHD).

Materials and methods

With Institutional Review Board approval, 21 consecutive neonates and young infants (1 day to 11 weeks old; median age of 3 days) who underwent a rapid two-sequence (MR angiography [MRA] and four-dimensional [4D] flow) MRI protocol with intravenous ferumoxytol without sedation (n = 17) or light sedation (n = 4) at 3 Tesla (T) (except one case at 1.5T) between June 2014 and February 2016 were retrospectively identified. Medical records were reviewed for indication, any complications, if further diagnostic imaging was performed after MRI, and surgical findings. Two radiologists scored the images in

SUBMITTER: Lai LM 

PROVIDER: S-EPMC5373922 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature